Thoracic Liposarcoma In An End Stage Renal Disease Patient

Rizwan Ishtiaq, Arslan Naeem, Iqbal Ratnani

Research output: Contribution to journalArticle

Abstract

Liposarcoma arising in the thoracic cavity is a rare entity. It is usually found in the retroperitoneal space and the extremities. No case of thoracic liposarcoma in a patient suffering from the end-stage renal disease has been reported in the literature. We herein present the first case of thoracic liposarcoma in a patient suffering from the end-stage renal disease. Metabolic disturbances, increased use of erythropoietin and increased diagnostic workup attributes to greater risk of cancer in patients suffering from renal failure. A chemotherapeutic drug, Trabectedin has been approved for advanced liposarcoma. Prognosis of such tumours depends on the size, location, and their histological subtype.

Original languageEnglish (US)
Pages (from-to)286-289
Number of pages4
JournalJournal of Ayub Medical College, Abbottabad : JAMC
Volume31
Issue number2
StatePublished - Apr 1 2019

Keywords

  • End-stage renal disease, Erythropoietin
  • Liposarcoma, Thoracic cavity, Trabectedin

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Thoracic Liposarcoma In An End Stage Renal Disease Patient'. Together they form a unique fingerprint.

Cite this